pyrazines has been researched along with Esthesioneuroblastoma, Olfactory in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahnert, P; Bauer, M; Bockmuehl, U; Erdal, H; Ganten, TM; Holland, H; Koschny, R; Krupp, W; Meixensberger, J; Stremmel, W; Sykora, J; Walczak, H | 1 |
1 other study(ies) available for pyrazines and Esthesioneuroblastoma, Olfactory
Article | Year |
---|---|
Bortezomib sensitizes primary human esthesioneuroblastoma cells to TRAIL-induced apoptosis.
Topics: Adult; Antineoplastic Agents; Apoptosis; Blotting, Western; Boronic Acids; Bortezomib; Cell Separation; Cells, Cultured; Drug Synergism; Esthesioneuroblastoma, Olfactory; Flow Cytometry; Humans; Immunohistochemistry; Male; Nose Neoplasms; Pyrazines; TNF-Related Apoptosis-Inducing Ligand | 2010 |